Recent changes in attitudes to the treatment of uveal melanomas have heightened the need for an accurate method of histological assessment of their prognosis. Most pathologists use a modification of the classification devised by Callender in 1931 .' This system consists of 4 histological groups-spindle cell A, spindle cell B, mixed cell, and epithelioid cell. The determination of the cell type, based on this classification, appears to be the most important parameter in assessing prognosis.2`Tumours composed in part (mixed cell) or completely of epithelioid cells have a relatively poor prognosis. Unfortunately it has been shown that there is often a considerable disparity in the histological grading of these tumours when they are examined by different pathologists.
In a study performed by Gass6 15 
Patients and methods

PATIENTS
Specimens were obtained from 7 patients who had an eye enucleated for a primary choroidal melanoma. The age of the patients in the study ranged from 40 to 88 years (mean 64-7 years). Patient 1 had been observed for 21/2 years prior to the enucleation. The tumour was relatively small, and little growth had been observed during that period. In view of the small size of the tumour and the patient's age enucleation was not proposed at the time of diagnosis. The eye was eventually enucleated because a painful thrombotic glaucoma had developed. Patient 3 had been observed for one year prior to enucleation. The tumour appeared to have arisen from a choroidal naevus. The eye removed from patient 7 had been diagnosed as having melanosis oculi with external pigmentation, heterochromia iridis, and a deeply pigmented choroid. The tumour in this eye was large, occupying at least half the globe.
METHODS
Immediately after enucleation the globe was opened, and the tumour was identified and biopsied, where possible from more than one site. The remainder of the tumour was left in situ in the globe and fixed in formol saline. The biopsy material removed was rapidly frozen and stored at -80°C until biochemical assay was performed.
Histological methods. After fixation in formol saline for a period of 24 to 48 hours sections from the globe containing the tumour were processed into paraffin wax. Standard 5 gm sections were cut and stained with haematoxylin and eosin. Histological grading by the modified Callender classification was performed independently by one of us (I.G.R.).
Immunohistochemistry. Paraffin sections were (Figs. 1, 2) . The strongest stainingwas found in patient 1, whose tumour was classified as spindle cell B containing spindle cell A elements. Of the 5 mixed cell tumours 3 were found to have equivocal staining for y enolase, and in 2 the staining for y enolase was absent.
Estimation of y enolase by biochemical assay. y Enolase was found in all 7 tumours studied (Table 1 ).
However, a marked variation in the levels present was found. The highest levels of y enolase, 46&6 ,ug/g and 40 0 gg/g were found in 2 of the spindle cell B tumours. All 5 of the mixed cell tumours had lower levels of the enzyme than the spindle celled tumours.
Discussion
Our results confirm the presence of y enolase within melanocytic tumours of the uveal tract. Although the series is small, the more benign spindle cell tumours appear to have a higher level of y enolase than those containing epithelioid cell clements. The highest level of enolase was present in a tumour which both clinically and histologically appeared the most benign. The lowest enolase level occurred in a mixed cell tumour (patient 7) which was large in size; its size may reflect a relatively fast growth rate. It has been established that large melanomas of the uveal tract carry a relatively poor prognosis.
A correlation between the biochemical assay and the immunoperoxidase staining was demonstrated. The 2 tumours with the highest biochemical assays both stained positively for the isoenzyme. The 2 tumours with the lowest levels of y enolase showed no appreciable staining.
Both methods of y enolase estimation may be of value in estimating the malignant potential of a uveal melanoma. The biochemical assay, although requiring the acquisition of fresh material in order to perform it, has distinct advantages. Firstly, unlike the immunoperoxidase method, it is quantitative rather than subjective. Secondly, the larger amount of material analysed by this technique renders it less susceptible to sampling error. Obviously further work on y enolase levels in uveal melanomas is necessary. This should include a prospective trial where enolase levels within uveal melanomas could be compared with long-term survival. Nevertheless we believe that y enolase estimation may provide an accurate quantitative method for assessing the malignant potential of uveal melanomas.
